AI in radiology – AI-enabled opportunistic screening in medical imaging

AIMed LOGO with link to their website
AIMed LOGO click to visit their website

AI in radiology a webinar by our friends at AIMED


Understanding the impact of AI enabled opportunistic screening in medical imaging

Webinar: Tue, Jun 1, 2021

12:00 PM – 1:00 PM EDT

05:00 PM – 06:00 PM BST

06:00 PM – 07:00 PM CET

Since the introduction of AI in radiology workflows we have seen a large number of solutions focused on clinical decision support in the acute setting, allowing for real-time reprioritization of worklists to expedite the reporting of urgent findings.

Whilst there is some value in these solutions, the ROI for procurement remains unclear.

As the demand for imaging continues to grow, and with radiology operating at the center of multiple care pathways, there is an opportunity to screen for high prevalence, chronic conditions which have clear downstream cost benefits, as well as significant improvement in patient outcomes.

Join this exclusive webinar

Discussing the impact of AI-enabled opportunistic screening in medical imaging and how this can positively impact on population health at scale.


  • DR SHAH ISLAM FRCR, Neuroradiologist, National Hospital for Neurology and Neurosurgery
  • ORIT WIMPFHEIMER, MD, Chief Medical Officer, Zebra Medical Vision

Who are AI Med?

Click to read a message from the AIMed Chairman and Founder

AI Med are a clinician led community exploring how AI can be used in Medicine and was founded in 2014 by Dr Anthony Chang. Founder AIMed Chang is Chief Artificial Intelligence Officer, Children’s Hospital of Orange County (CHOC) 
Chang is a practising paediatric cardiologist, CIIO at CHOC children’s and world-renowned expert on artificial intelligence (AI) who has an aim to bring together clinicians, physicians, c-suite executives and technology experts. Bringing them together so they can start a revolution in today’s Medicine and Healthcare for a data-smart tomorrow.

As an active clinician with a ‘data science‘ & ‘artificial intelligence‘ background, Chang saw the great potential that AI could have. In 2013 Chang initiated a series of meetings that examined the benefits, and limitations, of AI ‘for‘ medicine. “These meetings, called AI in Medicine (AIMed), have been successful since then in creating a ‘friendly‘ and ‘collaborative‘ gathering of minds as well as an ‘intellectually stimulating’ opportunity to learn about AI in medicine and healthcare.” Chang expresses that there are many clinicians of all sub-specialities that attend the AIMed meetings. However, the meetings also attract other stakeholders from within the industry such as data scientists, startup companies, hospital administrators, and investors.

Exclusive interviews with the key movers, shakers and thought leaders

The AI MED website is a great source of information with respect to artificial intelligence in medicine. It is also where you can sign up for their magazine and register your interest in upcoming events

AIMed LOGO with link to their website
AIMed LOGO click to visit their website

FibroFlutters in support of our friends at AI Med and the work that they do in the field of AI in Medicine and for bringing together clinicians. #AIMED